The risk of tMN was significantly higher after chemotherapy ± radiation exposure without G-CSF (HR = 2.01, 95% CI = 1.50 to 2.69, P < .0001; Table 1) after first primary bladder cancer. The gene discussed is CSF3; the disease is urinary bladder carcinoma.